Verge Genomics

Verge Genomics

    Company info:

  • 1-50
  • 2015
  • San Francisco, CA
  • 100-500M


vergegenomics.com

linkedin.com


Claim company profile

About company:

Verge Genomics is using machine learning and human genomics to accelerate drug discovery. Technology has the potential to revolutionize drug discovery by making the process cheaper and faster. Verge is capitalizing on this with their ConVERGE platform, which uses machine learning to map the complex causes of disease from their proprietary multi-omics database. Once the cause of disease has been identified, Verge uses their internal biology and chemistry platforms to select proprietary drug candidates that have high probability of clinical success. Verge’s first drug candidate for ALS treatment is expected to enter clinical trials in 2022. Their remaining portfolio includes drug development for Parkinson’s disease and Frontotemporal Dementia patients.

Jobs:

Verge Genomics
Research Associate/Senior Research Associate - Ne...
San Francisco, CA|16 days ago
Apply
Verge Genomics
Business Development Transactions Strategy & Evalu...
San Francisco, CA|44 days ago
Verge Genomics
Senior Scientist, Neurodegenerative Disease Modeli...
San Francisco, CA|100+ days ago
Verge Genomics
Future Opportunities: Scientist, Neurodegenerative...
San Francisco, CA|100+ days ago
Verge Genomics
Future Opportunities: Scientist, Target Validation...
San Francisco, CA|100+ days ago
Verge Genomics
Future Opportunities
San Francisco, CA|100+ days ago


© 2023 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy

Contact: recruit@workinbiotech.com